Clinical trial
Increased Heart Rhythm in Response to High-dose Intravenous Methylprednisolone Pulse Therapy of Moderate-to-severe Graves' Orbitopathy
NCT04391439 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Increased Heart Rhythm in Response to High-dose Intravenous Methylprednisolone Pulse Therapy of Moderate-to-severe Graves' Orbitopathy
- Lead sponsor
- Medical University of Warsaw
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2011
- Completion date
- February 20, 2020
- Enrollment
- 40 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
blood pressure, graves disease, graves ophthalmopathy, heart failure, heart rhythm disorder, hypertension